IBDEI084 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,3238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3238,1,3,0)
 ;;=3^Hypertension,Secondary
 ;;^UTILITY(U,$J,358.3,3238,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,3238,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,3239,0)
 ;;=I15.0^^28^249^45
 ;;^UTILITY(U,$J,358.3,3239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3239,1,3,0)
 ;;=3^Hypertension,Renovascular
 ;;^UTILITY(U,$J,358.3,3239,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,3239,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,3240,0)
 ;;=I95.1^^28^249^47
 ;;^UTILITY(U,$J,358.3,3240,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3240,1,3,0)
 ;;=3^Hypotension,Orthostatic
 ;;^UTILITY(U,$J,358.3,3240,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,3240,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,3241,0)
 ;;=I95.89^^28^249^48
 ;;^UTILITY(U,$J,358.3,3241,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3241,1,3,0)
 ;;=3^Hypotension,Other
 ;;^UTILITY(U,$J,358.3,3241,1,4,0)
 ;;=4^I95.89
 ;;^UTILITY(U,$J,358.3,3241,2)
 ;;=^5008079
 ;;^UTILITY(U,$J,358.3,3242,0)
 ;;=I25.9^^28^249^49
 ;;^UTILITY(U,$J,358.3,3242,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3242,1,3,0)
 ;;=3^Ischemic Heart Disease,Chronic,Unspec
 ;;^UTILITY(U,$J,358.3,3242,1,4,0)
 ;;=4^I25.9
 ;;^UTILITY(U,$J,358.3,3242,2)
 ;;=^5007144
 ;;^UTILITY(U,$J,358.3,3243,0)
 ;;=I89.0^^28^249^50
 ;;^UTILITY(U,$J,358.3,3243,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3243,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,3243,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,3243,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,3244,0)
 ;;=R01.1^^28^249^51
 ;;^UTILITY(U,$J,358.3,3244,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3244,1,3,0)
 ;;=3^Murmur,Cardia,Unspec
 ;;^UTILITY(U,$J,358.3,3244,1,4,0)
 ;;=4^R01.1
 ;;^UTILITY(U,$J,358.3,3244,2)
 ;;=^5019169
 ;;^UTILITY(U,$J,358.3,3245,0)
 ;;=I21.3^^28^249^52
 ;;^UTILITY(U,$J,358.3,3245,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3245,1,3,0)
 ;;=3^Myocardial Infarction,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,3245,1,4,0)
 ;;=4^I21.3
 ;;^UTILITY(U,$J,358.3,3245,2)
 ;;=^5007087
 ;;^UTILITY(U,$J,358.3,3246,0)
 ;;=I25.2^^28^249^53
 ;;^UTILITY(U,$J,358.3,3246,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3246,1,3,0)
 ;;=3^Myocardial Infarction,Old
 ;;^UTILITY(U,$J,358.3,3246,1,4,0)
 ;;=4^I25.2
 ;;^UTILITY(U,$J,358.3,3246,2)
 ;;=^259884
 ;;^UTILITY(U,$J,358.3,3247,0)
 ;;=I78.1^^28^249^54
 ;;^UTILITY(U,$J,358.3,3247,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3247,1,3,0)
 ;;=3^Nevus,Non-Neoplastic
 ;;^UTILITY(U,$J,358.3,3247,1,4,0)
 ;;=4^I78.1
 ;;^UTILITY(U,$J,358.3,3247,2)
 ;;=^269807
 ;;^UTILITY(U,$J,358.3,3248,0)
 ;;=Z95.0^^28^249^61
 ;;^UTILITY(U,$J,358.3,3248,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3248,1,3,0)
 ;;=3^Presence of Cardiac Pacemaker
 ;;^UTILITY(U,$J,358.3,3248,1,4,0)
 ;;=4^Z95.0
 ;;^UTILITY(U,$J,358.3,3248,2)
 ;;=^5063668
 ;;^UTILITY(U,$J,358.3,3249,0)
 ;;=I73.9^^28^249^55
 ;;^UTILITY(U,$J,358.3,3249,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3249,1,3,0)
 ;;=3^PVD,Unspec
 ;;^UTILITY(U,$J,358.3,3249,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,3249,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,3250,0)
 ;;=I80.9^^28^249^56
 ;;^UTILITY(U,$J,358.3,3250,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3250,1,3,0)
 ;;=3^Phlebitis & Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,3250,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,3250,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,3251,0)
 ;;=Z98.61^^28^249^57
 ;;^UTILITY(U,$J,358.3,3251,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,3251,1,3,0)
 ;;=3^Postprocedural State,Coronary Angioplasty
 ;;^UTILITY(U,$J,358.3,3251,1,4,0)
 ;;=4^Z98.61
 ;;^UTILITY(U,$J,358.3,3251,2)
 ;;=^5063742
